Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction

References

• Norhammar A, Tenerz A, Nilson G, Hamsten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140–4
   PubMed Web of Science ®Google Scholar
• Meier JJ, Deifuss S, Gallwitz B, Klamann A, Schmiegel W, Nauck MA. Influence of impaired glucose tolerance on long- term survival after acute myocardial infarction. Dtsch Med Wochenschr 2002; 127: 1123–9
   PubMedGoogle Scholar
• Choi MK, Lee WK, Kim GS, Kim HN, Park GC, Seo SH, et al. Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus. J Clin Endocrinol Metab 2005; 90: 175–80
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Ikewaki K, Yagi H, Nagasawa H, Imamoto S, Shibata T, et al. Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes. Diabetes Care 2005; 28: 1182–6
   PubMedGoogle Scholar
• Ramachandran A, Shanmugam MR, Chamukuttan S, Viswanathan V, Immaneni S, Jaakko T. High incidence of glucose intolerance in Asian-Indian subjects with acute coronary syndrome. Diabetes Care 2005; 28: 2492–6
   PubMedGoogle Scholar
• Tamita K, Katayama M, Takagi T, Akasaka T, Yamamuro A, Kaji S, et al. Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction. Circ J 2007; 71: 834–41
   PubMedGoogle Scholar
• Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Euro Heart J 2004; 25: 1990–7
   PubMed Web of Science ®Google Scholar
• Piconi L, Quagliaro L, Assaloni R, Da Ros R, Maier A, Zuodar G, et al. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev 2006; 22: 198–203
   PubMed Web of Science ®Google Scholar
• Oyama T, Miyasita Y, Watanabe H, Shirai K. The role of polyol pathway in high glucose-induced endothelial cell damages. Diabetes Res Clin Pract 2006; 73: 227–34
   PubMed Web of Science ®Google Scholar
• Blann AD. Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms?. Blood Coagul Fibrinolysis 2000; 11: 623–30
   PubMed Web of Science ®Google Scholar
• Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium. The first 30 years. Thromb Haemost 2006; 95: 49–55
   PubMed Web of Science ®Google Scholar
• Spiel AO, Gilbert JC, Jilma B. von Willebrand factor in cardiovascular disease: focus on acute coronary syndrome. Circulation 2008; 117: 1449–59
   PubMed Web of Science ®Google Scholar
• Sakai H, Goto S, Kim JY, Aoki N, Abe S, Ichikawa N, et al. Plasma concentration of von Willebrand factor in acute myocardial infarction. Thromb Haemost 2000; 84: 204–9
   PubMed Web of Science ®Google Scholar
• Dignat-George F, Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol 2000; 65: 215–20
   PubMed Web of Science ®Google Scholar
• Lee KW, Lip GY, Tayebjee M, Foster W, Blann AD. Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 2005; 105: 526–32
   PubMed Web of Science ®Google Scholar
• Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000; 21:1502–13.
   PubMed Web of Science ®Google Scholar
• British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart. 2005;91(suppl 5)v1–52.
   PubMedGoogle Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–53
   PubMed Web of Science ®Google Scholar
• Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183–97.
   PubMed Web of Science ®Google Scholar
• Woywodt A, Goldberg C, Scheer J, Regelsberger H, Haller H, Haubitz M. An improved assay for enumeration of circulating endothelial cells. Ann Hematol 2004; 83: 491–4
   PubMed Web of Science ®Google Scholar
• Boos CJ, Lane DA, Kang D, Goon PK, Blann AD, Lip GY. Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood. Thromb Thrombolysis 2006; 22: 125–31
   PubMedGoogle Scholar
• Leurs PB, Stolk RP, Hamulyak K, Oerle R, Grobbee DE, Wolffenbuttel BHR. Tissue factor pathway inhibitor and other endothelium-dependent haemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes. Diabetes Care 2002; 25: 1340–5
   PubMedGoogle Scholar
• Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet Med 1997; 14(Suppl 3)S45–9
   Google Scholar
• Singleton JR, Smith AG, Russel WJ, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes 2003; 52: 2867–73
   PubMed Web of Science ®Google Scholar
• Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47: 859–66
   PubMed Web of Science ®Google Scholar
• Singh R, Barden A, Mori T, Beilin L. Advanced glycation end products: a review. Diabetologia 2001; 44: 129–46
   PubMed Web of Science ®Google Scholar
• Van Oostorm AJ, Sijmonsma TP, Verseyden C, Jansen EH, de Koning EJ, Rabelink TJ, et al. Postprandial recruitment of neutrophils may contribute to endothelial function. J Lipid Res 2003; 44: 576–83
   PubMedGoogle Scholar
• Hanefeld M, Koehler C, Henkel E, Fuecker K, Schaper F, Temelkova-Kurktschiev T. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes. Diabet Med 2000; 17: 835–40
   PubMed Web of Science ®Google Scholar
• Temelkova-Kurktschiev TS, Koehler C, Schaper F, Leonhardt W, Henkel H, Hanefeld M. Post challenge plasma glucose and glycaemic spikes are more strongly associated with atherosclerosis than fasting glucose and HbA1c. Diabetes Care 2000; 23: 1830–4
   PubMed Web of Science ®Google Scholar
• Esposito, K, Giugliano, D, Nappo, F, Marfella, R; Campanian Postprandial Hyperglyaemia Study Group. Regression of carotid atherosclerosis by control of postprandial hyperglycaemia in type 2 diabetes mellitus. Circulation. 2004; 110: 214–9.
   PubMed Web of Science ®Google Scholar
• Deepa R, Velmurugan K, Arvind K, Sivaram P, Sientay C, Uday S, et al. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecules 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance—the Chennai Urban Rural Epidemilogy Study (CURES). Metabolism 2006; 55: 1232–8
   PubMed Web of Science ®Google Scholar
• Fritsche A, Haring H, Stumvoll M. White blood cell count as a predictor of glucose tolerance and insulin sensitivity. The role of inflammation in the pathogenesis of type 2 diabetes mellitus. Dtsch Med Wochenschr 2004; 129: 244–8
   PubMedGoogle Scholar
• Jessani S, Gangopadhyay K, Patel VJ, Lip GYH, Millane T. Should oral glucose tolerance be mandatory following acute myocardial infarction?. Int J Clin Pract 2007; 61: 680–3
   PubMedGoogle Scholar
• Ryden L, Standl E, Bartnik M, Van den Berghe E, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. The Task Force on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007; 28: 88–136
   PubMed Web of Science ®Google Scholar
• Ramaiya KL, Swai ABM, Alberti KG, McLarty D. Lifestyle changes decrease rates of glucose intolerance and cardiovascular (CVD) risk factors: a six intervention study in a high risk Hindu Indian sub-community. Diabetologia 1992; 35(suppl 1)A60
   Google Scholar
• Pan X-R, Li G-W, Hu Y-H, Wang J-X, Yang W-Y, An Z-X, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes study. Diabetes Care 1997; 20: 537–44
   PubMed Web of Science ®Google Scholar
• ; The DREAM Trial InvestigatorsBosch, J, Yusuf, S, Gerstein, HC, Pogue, J, Sheridan, P, Dagenais, G, , et al. Effect of ramipril on the incidence of diabetes. N Engl J Med. 2006; 355: 1551–62
   PubMedGoogle Scholar
• Hiralal R, Koo KY, Gerstein HC. Does pioglitazone prevent macrovascular events in patients with type 2 diabetes?. CMAJ. 2006; 174: 1090–1
   PubMedGoogle Scholar
• Van Gaal, LF, Rissanen, AM, Scheen, AJ, Ziegler, O, Rossner, S; for the RIO-Europe Study Group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in over weight patients: 1-year experience from the RIO-Europe study. Lancet 2005; 365: 1389–97.
   PubMed Web of Science ®Google Scholar
• Rendell MS, Jovanovic L. Targeting post prandial hyperglycaemia. Metabolism 2006; 55: 1263–81
   PubMed Web of Science ®Google Scholar
• Tenerz A, Norhammar A, Silveira A, Hamsten A, Nilsson G, Ryden L, et al. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 2003; 26: 2770–6
   PubMed Web of Science ®Google Scholar
• Boos CJ, Balakrishnan B, Blann AD, Lip GYH. The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: Implications for prognosis. J Thromb Haemost 2008; 6: 1841–50
   PubMed Web of Science ®Google Scholar
• Lee KW, Blann AD, Lip GYH. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow mediated dilatation] to tissue factor in acute coronary syndromes. Int J Cardiol 2006; 111: 302–8
   PubMed Web of Science ®Google Scholar